NEW YORK (GenomeWeb) – Researchers with the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium have identified a pair of proteins as possible keys to the development of drug resistance in triple-negative breast cancer (TNBC).
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.
Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.
The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.
In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.
This webinar will discuss how the Estonian Biobank, a cohort of more than 165,000 participants, is addressing industry challenges with data management and collaboration in the transition to precision medicine.
This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.